Vince Forlenza, president and CEO of Becton Dickinson & Co., just finished his two-year term as chairman of AdvaMed's board. This month, he handed over the reins to Nadim Yared, CEO of CVRx Inc. (Also see "Q&A With Nadim Yared: AdvaMed's Next Chair On Capital Formation And Global Challenges" - Medtech Insight, 4 August, 2016.)
AdvaMed-Chair Exit Interview: Vince Forlenza On Medtech Policy Priorities
BD CEO Vince Forlenza just finished his two-year term as board chairman of AdvaMed. For the most part, his successor will face the same priorities he did during his tenure: repealing the 2.3 percent medical device excise tax and reauthorizing device user fees. Forlenza spoke with Medtech Insight in this podcast interview.
